“It appears that the pharmaceutical sector has managed to find a solution to achieve growth during the times of economic slowdown. In 2009, the value of the pharmaceutical market in Poland will exceed PLN 25bn, which shows a significant improvement over the figure for 2008. On-line pharmacies will be the fastest growing distribution channel – a whopping 80% of the companies surveyed predict that distribution through this channel will develop faster than the pharmacy sales market as a whole”, said Monika Bartoszewicz, Partner, Audit Department, KPMG.

According to the study carried by PMR and KPMG, more than 60% of the surveyed companies describe the current market situation as good or very good. 40% of the surveyed companies said they planned to introduce 3 to 10 new drugs by the end of 2009.

“The 2008 year was one of the best for the pharmaceutical industry in the last decade, in part because of high GDP growth and related increases in the purchasing power of Polish consumers. Non-refunded OTC products, with dietary supplements at the helm, drove market growth”, says Karol Kolt, President of PMR’s Management Board.

Last year, the OTC drugs (over the counter) accounted for 34% of the pharmacy market in Poland, whereas in 2005, they accounted for around 30%. Close to half of 2008 market value was to a certain extent generated by sales of prescription preparations subject to reimbursement.